Neo-Bionica secures $5M from Breakthrough Victoria for medtech manufacturing
Summary
Neo-Bionica has received $5 million from Breakthrough Victoria to expand its manufacturing capability, facilities, and market presence. Founded in 2021 as a joint initiative of the Bionics Institute and the University of Melbourne, the company provides end-to-end medical device prototype development, clinical trials, and low-volume manufacturing support, specializing in bioelectronics and neurotechnology.
Why it matters
Neo-Bionica is unique in Australia, significantly speeding up the time it takes to develop and trial medical devices. By supporting local medtech innovators to design, develop, and manufacture implantable and wearable neurotechnology devices in Victoria, the company ensures life-saving technologies benefit local patients while creating up to 45 new jobs.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial